Cargando…
Nanoclays: Promising Materials for Vaccinology
Clay materials and nanoclays have gained recent popularity in the vaccinology field, with biocompatibility, simple functionalization, low toxicity, and low-cost as their main attributes. As elements of nanovaccines, halloysite nanotubes (natural), layered double hydroxides and hectorite (synthetic)...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9505858/ https://www.ncbi.nlm.nih.gov/pubmed/36146630 http://dx.doi.org/10.3390/vaccines10091549 |
_version_ | 1784796578227159040 |
---|---|
author | Govea-Alonso, Dania O. García-Soto, Mariano J. Betancourt-Mendiola, Lourdes Padilla-Ortega, Erika Rosales-Mendoza, Sergio González-Ortega, Omar |
author_facet | Govea-Alonso, Dania O. García-Soto, Mariano J. Betancourt-Mendiola, Lourdes Padilla-Ortega, Erika Rosales-Mendoza, Sergio González-Ortega, Omar |
author_sort | Govea-Alonso, Dania O. |
collection | PubMed |
description | Clay materials and nanoclays have gained recent popularity in the vaccinology field, with biocompatibility, simple functionalization, low toxicity, and low-cost as their main attributes. As elements of nanovaccines, halloysite nanotubes (natural), layered double hydroxides and hectorite (synthetic) are the nanoclays that have advanced into the vaccinology field. Until now, only physisorption has been used to modify the surface of nanoclays with antigens, adjuvants, and/or ligands to create nanovaccines. Protocols to covalently attach these molecules have not been developed with nanoclays, only procedures to develop adsorbents based on nanoclays that could be extended to develop nanovaccine conjugates. In this review, we describe the approaches evaluated on different nanovaccine candidates reported in articles, the immunological results obtained with them and the most advanced approaches in the preclinical field, while describing the nanomaterial itself. In addition, complex systems that use nanoclays were included and described. The safety of nanoclays as carriers is an important key fact to determine their true potential as nanovaccine candidates in humans. Here, we present the evaluations reported in this field. Finally, we point out the perspectives in the development of vaccine prototypes using nanoclays as antigen carriers. |
format | Online Article Text |
id | pubmed-9505858 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-95058582022-09-24 Nanoclays: Promising Materials for Vaccinology Govea-Alonso, Dania O. García-Soto, Mariano J. Betancourt-Mendiola, Lourdes Padilla-Ortega, Erika Rosales-Mendoza, Sergio González-Ortega, Omar Vaccines (Basel) Review Clay materials and nanoclays have gained recent popularity in the vaccinology field, with biocompatibility, simple functionalization, low toxicity, and low-cost as their main attributes. As elements of nanovaccines, halloysite nanotubes (natural), layered double hydroxides and hectorite (synthetic) are the nanoclays that have advanced into the vaccinology field. Until now, only physisorption has been used to modify the surface of nanoclays with antigens, adjuvants, and/or ligands to create nanovaccines. Protocols to covalently attach these molecules have not been developed with nanoclays, only procedures to develop adsorbents based on nanoclays that could be extended to develop nanovaccine conjugates. In this review, we describe the approaches evaluated on different nanovaccine candidates reported in articles, the immunological results obtained with them and the most advanced approaches in the preclinical field, while describing the nanomaterial itself. In addition, complex systems that use nanoclays were included and described. The safety of nanoclays as carriers is an important key fact to determine their true potential as nanovaccine candidates in humans. Here, we present the evaluations reported in this field. Finally, we point out the perspectives in the development of vaccine prototypes using nanoclays as antigen carriers. MDPI 2022-09-17 /pmc/articles/PMC9505858/ /pubmed/36146630 http://dx.doi.org/10.3390/vaccines10091549 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Govea-Alonso, Dania O. García-Soto, Mariano J. Betancourt-Mendiola, Lourdes Padilla-Ortega, Erika Rosales-Mendoza, Sergio González-Ortega, Omar Nanoclays: Promising Materials for Vaccinology |
title | Nanoclays: Promising Materials for Vaccinology |
title_full | Nanoclays: Promising Materials for Vaccinology |
title_fullStr | Nanoclays: Promising Materials for Vaccinology |
title_full_unstemmed | Nanoclays: Promising Materials for Vaccinology |
title_short | Nanoclays: Promising Materials for Vaccinology |
title_sort | nanoclays: promising materials for vaccinology |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9505858/ https://www.ncbi.nlm.nih.gov/pubmed/36146630 http://dx.doi.org/10.3390/vaccines10091549 |
work_keys_str_mv | AT goveaalonsodaniao nanoclayspromisingmaterialsforvaccinology AT garciasotomarianoj nanoclayspromisingmaterialsforvaccinology AT betancourtmendiolalourdes nanoclayspromisingmaterialsforvaccinology AT padillaortegaerika nanoclayspromisingmaterialsforvaccinology AT rosalesmendozasergio nanoclayspromisingmaterialsforvaccinology AT gonzalezortegaomar nanoclayspromisingmaterialsforvaccinology |